Successful treatment with mitoxantrone chemotherapy of acute disseminated intravascular coagulation due to metastatic androgen independent prostate cancer

Journal of Urology

Volumn 163, Issue 1, 2000, Pages 248-

  Smith, M R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

Drug therapy; Mitoxantrone; Prostatic neoplasms

Indexed keywords

MITOXANTRONE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BONE METASTASIS; CANCER DIAGNOSIS; CASE REPORT; DISEASE ASSOCIATION; HUMAN; MALE; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE CANCER; RECURRENT DISEASE; THROMBOCYTE COUNT;

EID: 0033992261     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)68026-3     Document Type: Article

References (4)

1. Lowe F.C. Somers W.J. The use of ketoconazole in the emergency management of disseminated intravascular coagulation due to metastatic prostatic cancer J Urol 137 1987 1000
2. Goldenberg S.L. Fenster H.N. Perler Z. Disseminated intravascular coagulation in carcinoma of prostate: role of estrogen therapy Urology 22 1983 130
3. Tannock I.F. Osoba D. Stockler M.R. Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points J Clin Oncol 14 1996 1756
4. Kantoff P.W. Halabi S. Conaway M. Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the Cancer and Leukemia Group B 9182 Study J Clin Oncol 17 1999 2506